Clinical Trials Browser

Phase 3 × Hematologic Neoplasms × trihexyltetradecylphosphonium chloride × Clear all

NCT05158608 2022-01-11

CY25

Phase 3 Unknown

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms